← 返回

诃子酸靶向 FBXO38 增强 NK 细胞介导的肺腺癌抗肿瘤免疫

英文原题:Chebulagic acid targets FBXO38 to enhance natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma.

查看英文原题

Chebulagic acid targets FBXO38 to enhance natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma.

PubMed 2026/01/17(内容时间) Hum Cell Q3 · IF 2.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肺腺癌(LUAD)是最常见且侵袭性最强的非小细胞肺癌类型。天然化合物作为潜在抗癌药物日益受到关注。Chebulagic acid(CA)是一种具有抗增殖活性的可水解鞣质,但其治疗LUAD的潜力尚未研究。本研究中的功能实验显示,CA处理显著抑制LUAD细胞增殖,并诱导线粒体依赖性凋亡。此外,CA通过增强LUAD细胞CCL5生成,促进自然杀伤(NK)细胞迁移。定量蛋白质组学发现,CA处理后FBXO38是上调最显著的蛋白。沉默FBXO38可消除CA诱导的CCL5生成和NK细胞迁移。体内实验显示,CA显著抑制小鼠肿瘤生长并增强NK细胞浸润,同时Ki67阳性增殖细胞减少、裂解型caspase-3阳性凋亡细胞增加,FBXO38表达上调。综上,研究结果表明,CA可能通过FBXO38/CCL5介导的NK细胞募集发挥抗LUAD作用。

展开英文摘要原文

Lung adenocarcinoma (LUAD), the most prevalent and aggressive form of non-small cell lung cancer. Natural compounds have gained increasing attention as potential anti-cancer agents. The therapeutic potential of chebulagic acid (CA)-a hydrolysable tannin with documented anti-proliferative properties-has not been investigated in LUAD. In the present study, functional experiments revealed that CA treatment markedly suppressed proliferation and induced mitochondrial-dependent apoptosis of LUAD cells.

In addition, CA augments natural killer (NK) cell migration by enhancing LUAD CCL5 production. Quantitative proteomics identified FBXO38 as the most significantly upregulated protein following CA treatment. FBXO38 silencing abrogated CA-induced CCL5 production and NK cell migration in LUAD cells.

The in vivo experiments showed that CA significantly inhibited tumor growth and enhanced NK cell infiltration in mice, accompanied by decreased Ki67 + proliferating cells, increased cleaved caspase-3 + apoptotic cells, and upregulated FBXO38 expression. Collectively, our findings demonstrate that CA may be exert anti-LUAD effects through FBXO38/CCL5-mediated NK cell recruitment.

论文信息

作者
Hu X、Sha R、Yang F、Chai J、Liu B、Xu X
第一作者单位
The First Clinical Medical School, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China.China
通讯作者单位
Department of Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No. 42, Wenhua West Road, Jinan, Shandong, People's Republic of China. jnxuxiaoqing@126.com.China
期刊
Human cell2026 Jan 17
原文标识
PubMed 41546764 · DOI 10.1007/s13577-026-01347-7